CH0210483332 (CH0210483332)

$80.7B
Market Cap
22.9
P/E Ratio
1.07
Beta
2.19%
Dividend Yield
Piotroski 8/9Altman Z 4.6 SafeROIC−WACC +1.6%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 4.6 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company demonstrates robust fundamental quality, evidenced by a Piotroski F-Score of 8/9 and an Altman Z-Score of 4.6, which collectively signal strong financial health and low bankruptcy risk. While the ROIC-WACC spread sits at +1.6%, indicating value creation above the cost of capital, the DuPont decomposition reveals that high profitability is driven primarily by a substantial gross margin of 66.9% rather than operational leverage or asset turnover; this is further underscored by a net margin of 12.9%. However, revenue growth remains modest at 3.8% year-over-year, suggesting that current earnings power relies heavily on pricing strength and cost control rather than top-line expansion, creating a profile typical of mature or niche businesses where efficiency outweighs scale for value generation.

Valuation metrics present a mixed picture relative to historical norms and sector peers. The current P/E ratio of 22.9x implies the market is pricing in expectations that exceed the company's realized growth rate of 3.8%, potentially compressing multiples if future performance does not accelerate. Conversely, the DCF model calculates a fair value of $57, which serves as an anchor for intrinsic worth independent of multiple expansion assumptions; this suggests the current price may be either fairly valued or slightly elevated depending on whether implied growth rates align with the conservative revenue trajectory provided. The divergence between the high margin profile and low-growth reality necessitates scrutiny of how much premium investors are willing to pay for durability versus scalability in the absence of sector context.

No specific risk factor deltas, insider transaction data, or Fama-French alpha metrics were supplied to refine the risk-reward assessment beyond the static financial scores already analyzed. Consequently, while the balance sheet and profitability indicators remain resilient, the limited revenue growth combined with a P/E multiple that may be stretched relative to its actual expansion rate warrants caution regarding future valuation sustainability absent further catalysts for top-line acceleration.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →9%11%13%
2%$66$53$45
3%$73$57$47
4%$84$62$50

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=11.0%, terminal growth 3%. Fair value $57 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
4.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

66.9%
Gross Margin
12.9%
Net Margin
12.6%
ROIC
11.0%
WACC
ROIC − WACC Spread: +1.6%— Positive spread.
+3.8%
Revenue Growth (YoY)
+16.5%
Earnings Growth (YoY)
3.3B
Free Cash Flow
52%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

Balance Sheet Health

0.85x
Debt / Equity
2.90x
Current Ratio
10.3x
Interest Coverage
-0.5x
Net Debt / EBITDA
4.21%
FCF Yield
6.5B
EBITDA

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

21.4
Forward P/E
PEG Ratio
3.95
Price/Book
940442
Avg Volume
$180.00
52W High
$120.60
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.4B
Tracked Passive Exposure
6
ETFs Holding CH0210483332
0.37%
Avg Weight in ETFs
$385B
Total ETF AUM

When investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell CH0210483332 shares regardless of CH0210483332's individual fundamentals. We estimate $1.4B of passive capital is structurally linked to CH0210483332 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in CH0210483332 to visualize passive redemption contagion across ETFs and collateral stocks.

CH0210483332 Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
CH0210483332EpicenterIEFAETFEFAETFSCHFETFNL0010273215Low RiskCH0012032048Low RiskNVDALow RiskCH0012005267Low RiskAAPLLow Risk
CH0210483332 Price Drop (%)0

If CH0210483332 (CH0210483332) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with CH0210483332. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

CH0210483332 Ownership Dynamics

Ticker
CH0210483332

Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

CH0210483332 Capital Efficiency

How efficiently does CH0210483332 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$3.3B
EBITDA
$6.5B
FCF Conversion
50%
Reinvestment Rate
50%
50% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
12.6%
ROIC − WACC Spread
1.6%

CH0210483332 converts 50% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 50% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 1.6% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare CH0210483332 to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.